Press "Enter" to skip to content

Tag: respiratory diseases

Long COVID puzzle pieces are falling into place – the picture is unsettling

Since 2020, the condition known as long COVID-19 has become a widespread disability affecting the health and quality of life of millions of people across the globe and costing economies billions of dollars in reduced productivity of employees and an overall drop in the work force.

The intense scientific effort that long COVID sparked has resulted in more than 24,000 scientific publications, making it the most researched health condition in any four years of recorded human history.

Long COVID is a term that describes the constellation of long-term health effects caused by infection with the SARS-CoV-2 virus. These range from persistent respiratory symptoms, such as shortness of breath, to debilitating fatigue or brain fog that limits people’s ability to work, and conditions such as heart failure and diabetes, which are known to last a lifetime.

Comments closed

Colorado reports avian flu infections in 5 people who culled sick poultry

The Colorado Department of Public Health and Environment (CDPHE) has reported five human H5 avian influenza infections in workers who were part of the response to a recent large outbreak at a layer farm, four of which have been confirmed by the US Centers for Disease Control and Prevention (CDC).

Patients have eye, respiratory symptoms

The patients have mild illness, including conjunctivitis and common respiratory symptoms. None were hospitalized, according to statements from the CDPHE. Though officials haven’t said if the virus on the poultry farm is the same as the B3.13 genotype infecting dairy cattle, conjunctivitis has also been reported in four dairy farm workers over the past few months.

Comments closed

New antibody treatment for RSV in infants highly effective in reducing hospitalisations

A new antibody treatment could reduce by 80 per cent the numbers of babies and young children admitted to hospital with respiratory syncytial virus (RSV), a “groundbreaking” study has found.

Published in the New England Journal of Medicine on Thursday, the study involved 8,058 healthy babies aged up to 12 months from the UK, France and Germany, who were approaching their first RSV season. Half were randomly assigned to receive the antibody nirsevimab by injection, while 4,021 babies received standard care.

Of the babies who received the treatment, only 11 (0.3 per cent) were hospitalised, in comparison with the 60 babies (1.5 per cent) who were hospitalised after receiving just the standard care.

Comments closed

Pneumonia outbreak in Chinese kids linked to known pathogens

The surge in respiratory infections in young children in northern China is being driven primarily by known viral and bacterial infections and not by a novel pathogen, the World Health Organization (WHO) said late last week in an update.

Comments closed

Substantial decrease noted in severe respiratory illness during first 2 years of pandemic

Compared to the 3 years prior to the pandemic, children with medically complex conditions and otherwise healthy children saw decreases in severe non-COVID respiratory illnesses in 2020 and 2021, the authors of a study yesterday note in JAMA Network Open.

The cross-sectional study, based on 139,078 respiratory hospitalizations in Canada, shows that the mitigation efforts used during the first several months of COVID-19 likely prevented serious outcomes from respiratory illness complications, including hospitalizations, intensive care unit (ICU) admissions, and death.

Comments closed

Un médicament québécois démontre son efficacité contre la COVID-19

A cocktail of antibodies developed by the Quebec company Immune Biosolutions has proven its effectiveness in relieving respiratory symptoms caused by COVID-19 in the acute phase of the disease.

Comments closed

Are repeat COVID infections dangerous? What the science says

Nature

April 26, 2023

“People with repeat infections were twice as likely to die and three times as likely to be hospitalized, have heart problems or experience blood clots than were people who were infected only once. In a surprising twist, vaccination status didn’t seem to have an impact — although other studies show vaccines to be protective. Whether these results hold true for the general population is up for debate. The Veterans Affairs cohort was made up mostly of older white men, which is not representative of the wider population.”

Comments closed

Long COVID stemmed from mild cases of COVID-19 in most people

Even mild COVID-19 cases can have major and long-lasting effects on people’s health. That is one of the key findings from our recent multicountry study on long COVID-19—or long COVID—recently published in the Journal of the American Medical Association.

Comments closed